Cipla, GlaxoSmithkline feature in Fortune ‘Change the World’ list
Fortune lauded Cipla for “driving prices down for much-needed medications
Author
Lupin receives FDA approval for potassium chloride extended-release capsules
It is indicated for the treatment of patients with hypokalemia, with or without metabolic alkalosis, in digitalis intoxications…
Cystic fibrosis therapies will push Vertex ahead of GSK in respiratory market by 2022: GBI Research
The respiratory market is expected to rise considerably from $28.1 billion in 2015 to $46.6 billion by 2022, at a CAGR of 7.5 per…
Strides Shasun’s Q1 FY17 pharma revenues grow 43 per cent YoY
To carve out API commodity division as increasing compliance costs cut margins
Veeva opens office in Mumbai to expand presence in APAC
The team in Mumbai will serve the needs for cloud and mobility solutions among life sciences customers throughout India,…
Piramal Enterprises signs agreement to acquire Ash Stevens, US CDMO for HPAPIs
The facility has approvals from US, EU, Australia, Japan, Korea, Mexico regulatory agencies
Lonza to acquire InterHealth Nutraceuticals
The acquisition is expected to expand Lonza’s offerings into new areas such as cognitive and diabetic health
Cipla appoints Umang Vohra as MD & Global CEO; Samina Vaziralli as Executive VC
Both will take charge of their new positions from September 1, 2016
Glenmark’s announces 23.96% net profit at Rs 2267.80 million for Q1 FY 2016-17
Consolidated revenue was at Rs 19,430.52 million, recording an increase of 17.92 per cent
HK College of Pharmacy organises Mentor-Mentee Programme
It aims at providing continuous practical guidance to current HKCP students (mentees) by experienced alumni from the pharma sector…